home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies
Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies
Post navigation
Previous Post
Previous
Alumis to Participate in Upcoming September Investor Conferences
Next Post
Next
Circle Pharma announces preclinical data poster presentation of CID-078, a first-and-only-in-class Cyclin A/B RxL inhibitor at the 2024 World Conference on Lung Cancer